Amid
the growing coronavirus pandemic, the Ministry of Health and Family Welfare in
exercise of the powers conferred by Section 26B of the Drugs and Cosmetics Act,
1940 (23 of 1940), has declared hydroxychloroquine (HCQS) drug as a schedule H1
drug. ICMR has suggested that hydroxychloroquine be used in high risk cases of
coronavirus (COVID-19). Schedule H1 drug means it can’t be sold without the
prescription of a registered medical practitioner.
As
per health ministry, these drugs should be sold in India with some conditions. It
includes,
v The Schedule H1 drug supply
should be registered in a separate register, which records the name and address
of the prescriber, the name of the patient, the name of the drug & the
quantity supplied and such records will be maintained for 3- years and is
available for inspection.
v On the strip of
hydroxychloroquine drugs it is marked ‘RX’ in red color and will be displayed
on the left top corner of the label.
No comments:
Post a Comment